FDA cleared the Hive™ Standalone Cervical System and Hive™ C Interbody System from NanoHive Medical, LLC on Feb 13, 2026 under K254105, a traditional 510(k). The device falls under product code ODP, Intervertebral Fusion Device With Bone Graft, Cervical, regulated at 21 CFR 888.3080 as a Class 2 device. The review panel was Orthopedic.

FDA logged the submission as received on Dec 19, 2025. The decision came 56 days later, inside the 90 FDA-day goal for a 510(k).

This is the only decision on file for NanoHive Medical, LLC in the last 12 months of the tracker.